Health
Accuhealth Partners With Telli Health To Provide The World's First IoT FDA Approved SpO2 Meter Powered By Sigfox
MCALLEN, Texas, Oct. 29, 2020 /PRNewswire/ -- Accuhealth announced today that they are proud to partner withTelli Health to provide the world's first FDA certified and approved, plug-and-play Sigfox SpO2 meter. Telli Health developed the hardware and Accuhealth bought the first 5,000 units and wi...
2020-10-29 21:00
1943
NorthStar Commended by Frost & Sullivan for its RadioGenix(R) System, an Innovative, High-Tech Separation Platform for Processing Non-Uranium-based Mo-99
The RadioGenix® System addresses molybdenum-99 (Mo-99) availability, nuclear proliferation, and environmental concerns to drive the U.S. medical radioisotope industry SANTA CLARA, Calif., Oct. 29, 2020 /PRNewswire/ -- Based on its recent analysis of the North American nuclear medicine imaging ma...
2020-10-29 21:00
1798
Frost & Sullivan's 2020 India Best Practices Awards Lauded Companies Showcasing Best Practices in Innovation, Performance, and Growth
19 awards were presented to companies for their exemplary performance at the 7th edition of these Awards MUMBAI, India, Oct. 29, 2020 /PRNewswire/ -- Frost & Sullivan's India Best Practices Awards were hosted on a virtual platform on October 28, 2020. These awards are presented each year to comp...
2020-10-29 20:42
1975
TytoCare Commended by Frost & Sullivan for Its Highly Accessible and Complete Remote Medical Examination Platform
Its proprietary algorithms and AI-based solutions improve patient stratification and deliver exceptional value during the COVID-19 pandemic and beyond SANTA CLARA, Calif., Oct. 29, 2020 /PRNewswire/ -- Based on its recent analysis of the North American remote medical examination platform market,...
2020-10-29 20:00
2370
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide
SEOUL, South Korea, Oct. 29, 2020 /PRNewswire/ -- Expectations are increasing as a Korean bio-tech company has succeeded in solving the problem of low absorption which has been one of the biggest obstacles for the repositioning of Niclosamide, an anthelmintic, as the first orally ingested treatme...
2020-10-29 20:00
7125
A Global Push to Increase Awareness, Action and Access to Thrombectomy Care for Stroke Patients is Underway
The Society of Vascular and Interventional Neurology together with MT2020 will distribute a report detailing their global initiative to reduce death and disability in stroke patients MIAMI, Oct. 29, 2020 /PRNewswire/ -- Mission Thrombectomy 2020+ (MT2020+), a global campaign of SVIN (Society of ...
2020-10-29 19:00
1458
Complete Data from Connect Biopharma's Phase 1b Study of CBP-201 Demonstrate Rapid, Early and Continuous Improvement in Patient Quality of Life and Atopic Dermatitis (AD) Symptoms
Results from study in adult patients with moderate-to-severe AD presented at EADV Congress SAN DIEGO and TAICANG, SUZHOU, China, Oct. 29, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune mo...
2020-10-29 19:00
1703
Kintor Pharmaceutical's COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment
SUZHOU, China, Oct. 29, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (Kintor Pharmaceutical, stock code 9939.HK) is delighted to announced that the clinical trial (ClinicalTrials.gov identifier: NCT04446429, registered by Dr. Andy Goren and Applied Biology) of its anti-androgen treatment Pro...
2020-10-29 18:24
3455
Breathonix announces 60 secs, on-site, non-intrusive rapid breath test for COVID-19
SINGAPORE, Oct. 29, 2020 /PRNewswire/ -- Breathonix has developed a breath test to detect COVID-19 within a minute in-situ (on-site), achieving an accuracy above 90% at a recent pilot clinical trial involving 180 patients. BREATHONIX BREATHLYZER TECHNOLOGY The principle of the breath test is fun...
2020-10-29 17:22
1724
8th Anniversary of "SMIC Liver Transplant Program" - Over 500 Children Saved
SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Semiconductor Manufacturing International Corporation ("SMIC", SSE STAR MARKET: 688981; SEHK: 00981; OTCQX: SMICY), one of the leading foundries in the world, and Mainland China's largest foundry in scale, broadest in technology coverage, and most comprehen...
2020-10-29 17:01
6261
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa
* Tadekinig alfa is a novel IL-18 binding protein in pivotal Phase 3 testing for orphan disease IL-18 driven monogenic Hemophagocytic Lymphohistiocytosis (HLH) * WuXi Biologics to undertake commercial-scale manufacturing to support U.S. market launch SHANGHAI and LAUSANNE, Switzerland, Oct. 2...
2020-10-29 17:00
2214
Human-Machine Competition: Ping An's AskBob Doctor's AI Matches Doctors' Capabilities in Cardiovascular Disease Management
HONG KONG and SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 02318; SSE: 601318) announced thatPing An's AskBob Doctor has demonstrated that its artificial intelligence (AI) capabilities in cardiovascular disease ...
2020-10-29 16:50
5169
Tencent Cloud Backs the 11th Ageing Asia 2020 - World Ageing Festival with its Innovative Cloud Conferencing Solutions
SINGAPORE, Oct. 29, 2020 /PRNewswire/ -- Tencent Cloud today announced its support for the11th Ageing Asia 2020 – World Ageing Festival (AA2020 – WAF) through its secure and stableTencent Cloud Conference (TCC) solutions, offering global audiences a seamless and high-quality online exhibition vie...
2020-10-29 11:40
1531
Deep Longevity and SquareOne Wellness Partner on Deep Biomarkers of Aging and Longevity
HONG KONG, Oct. 28, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK) today announced that Deep Longevity, Inc, a company recently acquired by the Group which is a pioneer in deep biomarkers of agin...
2020-10-29 09:57
5068
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia
SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, today announced that Australian regulatory authorities have approved it...
2020-10-29 09:35
1727
INC Consumer Study Finds Energy Boosting and Digestive Healthy Foods Among the Fastest Growing Trends, with Immune Support Expected to Grow
REUS, Spain, Oct. 29, 2020 /PRNewswire/ -- Consuming foods that boost energy, and support digestive health are among the largest and fastest growing consumer trends. In a recent consumer trend study, it was found that these two markets are forecasted to be the fastest growers among the health and...
2020-10-29 09:00
2600
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center
INCHEON, South Korea and SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- At a virtual ceremony today, Samsung Biologics (KRX: 207940.KS) announced the grand opening of its first US CDO R&D Center inSan Francisco, bringing its contract development services closer to global clients. As the "Next Door ...
2020-10-29 08:38
6449
CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate
* CStone to acquire exclusive rights for development and commercialization outsideSouth Korea for LCB71, an ROR1 antibody drug conjugate * Agreement adds to CStone's pipeline a potential first-in-class/best-in-class drug candidate with monotherapy and combination applications for a range of c...
2020-10-29 07:15
3277
BioInvent Completes First Licensing Agreement in Greater China, Advised by MSQ Ventures
NEW YORK, Oct. 29, 2020 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") announced today that its client, BioInvent International, AB ("BioInvent"), has successfully entered into a licensing agreement with CASI Pharmaceuticals, Inc. ("CASI") for the development and commercialization of BI-1206 in theGreat...
2020-10-29 02:51
2422
Daewoong Pharmaceutical's COVID-19 Treatment Candidate Also Highly Effective against Influenza Virus
SEOUL, South Korea, Oct. 28, 2020 /PRNewswire/ -- Daewoong Pharmaceutical, a South Korean pharmaceutical giant announced that its Covid-19 treatment candidate of sustained-release niclosamide (DWRX2003) also showed promising study results for a fight against the upcoming 'Twindemic' involving COV...
2020-10-28 22:36
1433
Week's Top Stories
Most Reposted
MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship
[Picked up by 331 media titles]
2024-05-23 10:00
SINGAPORE'S XSQUARE TECHNOLOGIES SECURES S$10.5M IN SERIES A FUNDING LED BY WAVEMAKER PARTNERS
[Picked up by 326 media titles]
2024-05-23 10:00Unlock the Future of Innovation: Taiwan's Premier Hardware Expo Hits the Global Stage This October
[Picked up by 314 media titles]
2024-05-24 09:41
Ultima Markets partnered with Willis Towers Watson (WTW) to offer US$1 million in fund insurance
[Picked up by 303 media titles]
2024-05-24 12:00
Getac Announces World's First AI-Ready Rugged Laptop
[Picked up by 302 media titles]
2024-05-29 08:00
Most Read
MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship
2024-05-23 10:00
12331
Revolutionising Cardiac Care at Pantai Hospital Kuala Lumpur
2024-05-23 11:22
10651
